THE ROLE OF P53/MDM2 PATHWAY ABNORMALITIES IN NEUROBLASTOMA PROGNOSIS

被引：0
|
作者：
Svergun, N. [1 ]
Klymnyuk, G. [2 ]
Khranovska, N. [1 ]
Skachkova, O. [1 ]
Inomistova, M. [1 ]
Pavlyk, S. [2 ]
Shaida, O. [2 ]
机构：
[1] Natl Canc Inst MPH Ukraine, Dept Expt Oncol, Kiev, Ukraine
[2] Natl Canc Inst MPH Ukraine, Children Oncol Dept, Kiev, Ukraine
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-370
引用
收藏
页码：S336 / S336
页数：1
相关论文
共 50 条
  • [1] High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma
    Carr-Wilkinson, Jane
    O'Toole, Kieran
    Wood, Katrina M.
    Challen, Christine C.
    Baker, Angela G.
    Board, Julian R.
    Evans, Laura
    Cole, Michael
    Cheung, Nai-Kong V.
    Boos, Joachim
    Koehler, Gabriele
    Leuschner, Ivo
    Pearson, Andrew D. J.
    Lunec, John
    Tweddle, Deborah A.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (04) : 1108 - 1118
  • [2] The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma
    Waters, Alicia M.
    Beierle, Elizabeth A.
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (01) : 46 - 51
  • [3] Mdm2 and the p53 pathway in human pituitary adenomas
    Suliman, M
    Royds, J
    Cullen, D
    Timperley, W
    Powell, T
    Battersby, R
    Jones, TH
    [J]. CLINICAL ENDOCRINOLOGY, 2001, 54 (03) : 317 - 325
  • [4] ABNORMALITIES OF THE P53 MDM2 AND DCC GENES IN HUMAN LEIOMYOSARCOMAS
    PATTERSON, H
    GILL, S
    FISHER, C
    LAW, MG
    JAYATILAKE, H
    FLETCHER, CDM
    THOMAS, M
    GRIMER, R
    GUSTERSON, BA
    COOPER, CS
    [J]. BRITISH JOURNAL OF CANCER, 1994, 69 (06) : 1052 - 1058
  • [5] P53 Mdm2 Inhibitors
    Khoury, Kareem
    Doemling, Alex
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678
  • [6] MDM2与p53
    金晶
    刘耕陶
    [J]. 癌症, 2001, (06) : 663 - 666
  • [7] MDM2 and BCL-2: to p53 or not to p53?
    Wang, Eunice S.
    [J]. BLOOD, 2023, 141 (11) : 1237 - 1238
  • [8] Binding of an inhibitor of the p53/MDM2 interaction to MDM2
    Duncan, SJ
    Cooper, MA
    Williams, DH
    [J]. CHEMICAL COMMUNICATIONS, 2003, (03) : 316 - 317
  • [9] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Christine Wasylyk
    Roberto Salvi
    Manuela Argentini
    Christine Dureuil
    Isabelle Delumeau
    Joseph Abecassis
    Laurent Debussche
    Bohdan Wasylyk
    [J]. Oncogene, 1999, 18 : 1921 - 1934
  • [10] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Wasylyk, C
    Salvi, R
    Argentini, M
    Dureuil, C
    Delumeau, I
    Abecassis, J
    Debussche, L
    Wasylyk, B
    [J]. ONCOGENE, 1999, 18 (11) : 1921 - 1934
12345